ArticleLeukemia2022

CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia.

Xiuli Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.